Global Immune Check Point Inhibitor Market Research Report 2020

Table of Contents

1 Immune Check Point Inhibitor Market Overview

• 1.1 Product Overview and Scope of Immune Check Point Inhibitor
• 1.2 Immune Check Point Inhibitor Segment by Type
  • 1.2.1 Global Immune Check Point Inhibitor Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 CTLA 4
  • 1.2.3 PD 1
  • 1.2.4 Others
• 1.3 Immune Check Point Inhibitor Segment by Application
  • 1.3.1 Immune Check Point Inhibitor Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Medical Care
  • 1.3.3 Experiment
  • 1.3.4 Others
• 1.4 Global Immune Check Point Inhibitor Market Size Estimates and Forecasts
  • 1.4.1 Global Immune Check Point Inhibitor Revenue 2015-2026
  • 1.4.2 Global Immune Check Point Inhibitor Sales 2015-2026
  • 1.4.3 Immune Check Point Inhibitor Market Size by Region: 2020 Versus 2026

2 Global Immune Check Point Inhibitor Market Competition by Manufacturers

• 2.1 Global Immune Check Point Inhibitor Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Immune Check Point Inhibitor Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Immune Check Point Inhibitor Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Immune Check Point Inhibitor Manufacturing Sites, Area Served, Product Type
• 2.5 Immune Check Point Inhibitor Market Competitive Situation and Trends
  • 2.5.1 Immune Check Point Inhibitor Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Immune Check Point Inhibitor Players (Opinion Leaders)

3 Immune Check Point Inhibitor Retrospective Market Scenario by Region

• 3.1 Global Immune Check Point Inhibitor Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Immune Check Point Inhibitor Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Immune Check Point Inhibitor Market Facts & Figures by Country
  • 3.3.1 North America Immune Check Point Inhibitor Sales by Country
  • 3.3.2 North America Immune Check Point Inhibitor Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Immune Check Point Inhibitor Market Facts & Figures by Country
  • 3.4.1 Europe Immune Check Point Inhibitor Sales by Country
  • 3.4.2 Europe Immune Check Point Inhibitor Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Immune Check Point Inhibitor Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Immune Check Point Inhibitor Sales by Region
  • 3.5.2 Asia Pacific Immune Check Point Inhibitor Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Immune Check Point Inhibitor Market Facts & Figures by Country
  • 3.6.1 Latin America Immune Check Point Inhibitor Sales by Country
  • 3.6.2 Latin America Immune Check Point Inhibitor Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Immune Check Point Inhibitor Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Immune Check Point Inhibitor Sales by Country
  • 3.7.2 Middle East and Africa Immune Check Point Inhibitor Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Immune Check Point Inhibitor Historic Market Analysis by Type

• 4.1 Global Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
• 4.2 Global Immune Check Point Inhibitor Revenue Market Share by Type (2015-2020)
• 4.3 Global Immune Check Point Inhibitor Price Market Share by Type (2015-2020)
• 4.4 Global Immune Check Point Inhibitor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Immune Check Point Inhibitor Historic Market Analysis by Application

• 5.1 Global Immune Check Point Inhibitor Sales Market Share by Application (2015-2020)
• 5.2 Global Immune Check Point Inhibitor Revenue Market Share by Application (2015-2020)
• 5.3 Global Immune Check Point Inhibitor Price by Application (2015-2020)

6 Company Profiles and Key Figures in Immune Check Point Inhibitor Business

• 6.1 Advaxis
  • 6.1.1 Corporation Information
  • 6.1.2 Advaxis Description, Business Overview and Total Revenue
  • 6.1.3 Advaxis Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Advaxis Products Offered
  • 6.1.5 Advaxis Recent Development
• 6.2 Agenus
  • 6.2.1 Agenus Immune Check Point Inhibitor Production Sites and Area Served
  • 6.2.2 Agenus Description, Business Overview and Total Revenue
  • 6.2.3 Agenus Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Agenus Products Offered
  • 6.2.5 Agenus Recent Development
• 6.3 Amgen
  • 6.3.1 Amgen Immune Check Point Inhibitor Production Sites and Area Served
  • 6.3.2 Amgen Description, Business Overview and Total Revenue
  • 6.3.3 Amgen Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Amgen Products Offered
  • 6.3.5 Amgen Recent Development
• 6.4 Bristol Myers Squibb
  • 6.4.1 Bristol Myers Squibb Immune Check Point Inhibitor Production Sites and Area Served
  • 6.4.2 Bristol Myers Squibb Description, Business Overview and Total Revenue
  • 6.4.3 Bristol Myers Squibb Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Bristol Myers Squibb Products Offered
  • 6.4.5 Bristol Myers Squibb Recent Development
• 6.5 Faron Pharmaceuticals
  • 6.5.1 Faron Pharmaceuticals Immune Check Point Inhibitor Production Sites and Area Served
  • 6.5.2 Faron Pharmaceuticals Description, Business Overview and Total Revenue
  • 6.5.3 Faron Pharmaceuticals Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Faron Pharmaceuticals Products Offered
  • 6.5.5 Faron Pharmaceuticals Recent Development
• 6.6 Genentech
  • 6.6.1 Genentech Immune Check Point Inhibitor Production Sites and Area Served
  • 6.6.2 Genentech Description, Business Overview and Total Revenue
  • 6.6.3 Genentech Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Genentech Products Offered
  • 6.6.5 Genentech Recent Development
• 6.7 Genocea
  • 6.6.1 Genocea Immune Check Point Inhibitor Production Sites and Area Served
  • 6.6.2 Genocea Description, Business Overview and Total Revenue
  • 6.6.3 Genocea Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Genocea Products Offered
  • 6.7.5 Genocea Recent Development
• 6.8 Incyte Corporation
  • 6.8.1 Incyte Corporation Immune Check Point Inhibitor Production Sites and Area Served
  • 6.8.2 Incyte Corporation Description, Business Overview and Total Revenue
  • 6.8.3 Incyte Corporation Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Incyte Corporation Products Offered
  • 6.8.5 Incyte Corporation Recent Development
• 6.9 Innate Pharma
  • 6.9.1 Innate Pharma Immune Check Point Inhibitor Production Sites and Area Served
  • 6.9.2 Innate Pharma Description, Business Overview and Total Revenue
  • 6.9.3 Innate Pharma Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Innate Pharma Products Offered
  • 6.9.5 Innate Pharma Recent Development
• 6.10 Kite Pharma
  • 6.10.1 Kite Pharma Immune Check Point Inhibitor Production Sites and Area Served
  • 6.10.2 Kite Pharma Description, Business Overview and Total Revenue
  • 6.10.3 Kite Pharma Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 Kite Pharma Products Offered
  • 6.10.5 Kite Pharma Recent Development
• 6.11 MacroGenics
  • 6.11.1 MacroGenics Immune Check Point Inhibitor Production Sites and Area Served
  • 6.11.2 MacroGenics Immune Check Point Inhibitor Description, Business Overview and Total Revenue
  • 6.11.3 MacroGenics Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.11.4 MacroGenics Products Offered
  • 6.11.5 MacroGenics Recent Development
• 6.12 Merck
  • 6.12.1 Merck Immune Check Point Inhibitor Production Sites and Area Served
  • 6.12.2 Merck Immune Check Point Inhibitor Description, Business Overview and Total Revenue
  • 6.12.3 Merck Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.12.4 Merck Products Offered
  • 6.12.5 Merck Recent Development
• 6.13 NewLink Genetics Corp
  • 6.13.1 NewLink Genetics Corp Immune Check Point Inhibitor Production Sites and Area Served
  • 6.13.2 NewLink Genetics Corp Immune Check Point Inhibitor Description, Business Overview and Total Revenue
  • 6.13.3 NewLink Genetics Corp Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.13.4 NewLink Genetics Corp Products Offered
  • 6.13.5 NewLink Genetics Corp Recent Development
• 6.14 Sorrento Therapeutics
  • 6.14.1 Sorrento Therapeutics Immune Check Point Inhibitor Production Sites and Area Served
  • 6.14.2 Sorrento Therapeutics Immune Check Point Inhibitor Description, Business Overview and Total Revenue
  • 6.14.3 Sorrento Therapeutics Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.14.4 Sorrento Therapeutics Products Offered
  • 6.14.5 Sorrento Therapeutics Recent Development
• 6.15 TG Therapeutics
  • 6.15.1 TG Therapeutics Immune Check Point Inhibitor Production Sites and Area Served
  • 6.15.2 TG Therapeutics Immune Check Point Inhibitor Description, Business Overview and Total Revenue
  • 6.15.3 TG Therapeutics Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
  • 6.15.4 TG Therapeutics Products Offered
  • 6.15.5 TG Therapeutics Recent Development

7 Immune Check Point Inhibitor Manufacturing Cost Analysis

• 7.1 Immune Check Point Inhibitor Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Immune Check Point Inhibitor
• 7.4 Immune Check Point Inhibitor Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Immune Check Point Inhibitor Distributors List
• 8.3 Immune Check Point Inhibitor Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Immune Check Point Inhibitor Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Immune Check Point Inhibitor by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Immune Check Point Inhibitor by Type (2021-2026)
• 10.2 Immune Check Point Inhibitor Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Immune Check Point Inhibitor by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Immune Check Point Inhibitor by Application (2021-2026)
• 10.3 Immune Check Point Inhibitor Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Immune Check Point Inhibitor by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Immune Check Point Inhibitor by Region (2021-2026)
• 10.4 North America Immune Check Point Inhibitor Estimates and Projections (2021-2026)
• 10.5 Europe Immune Check Point Inhibitor Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Immune Check Point Inhibitor Estimates and Projections (2021-2026)
• 10.7 Latin America Immune Check Point Inhibitor Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Immune Check Point Inhibitor Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List